Author:
Mamtani Anita,Morrow Monica
Publisher
Springer Science and Business Media LLC
Reference5 articles.
1. Hortobagyi GN, Ames FC, Buzdar AU, et al. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer. 1988;62:2507–16.
2. Bonadonna G, Valagussa P. Combined modality approach for high-risk breast cancer: the Milan Cancer Institute experience. Surg Oncol Clin North Am. 1995;4:701–14.
3. Huang E, McNeese MD, Strom EA, et al. Locoregional treatment outcomes for inoperable anthracycline-resistant breast cancer. Int J Radiat Oncol Biol Phys. 2002;53:1225–33.
4. Buchholz TA, Hill BS, Tucker SL, et al. Factors predictive of outcome in patients with breast cancer refractory to neoadjuvant chemotherapy. Cancer J. 2001;7:413–20.
5. Mamtani A, Sevilimedu V, Vincent A, Morrow M. Local recurrence is frequent after heroic mastectomy for classically inoperable breast cancers. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-10764-x.